103 related articles for article (PubMed ID: 24439526)
1. Histone deacetylase inhibitor- and PMA-induced upregulation of PMCA4b enhances Ca2+ clearance from MCF-7 breast cancer cells.
Varga K; Pászty K; Padányi R; Hegedűs L; Brouland JP; Papp B; Enyedi A
Cell Calcium; 2014 Feb; 55(2):78-92. PubMed ID: 24439526
[TBL] [Abstract][Full Text] [Related]
2. Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells.
Varga K; Hollósi A; Pászty K; Hegedűs L; Szakács G; Tímár J; Papp B; Enyedi Á; Padányi R
BMC Cancer; 2018 Oct; 18(1):1029. PubMed ID: 30352569
[TBL] [Abstract][Full Text] [Related]
3. Isoform-specific up-regulation of plasma membrane Ca2+ATPase expression during colon and gastric cancer cell differentiation.
Ribiczey P; Tordai A; Andrikovics H; Filoteo AG; Penniston JT; Enouf J; Enyedi A; Papp B; Kovács T
Cell Calcium; 2007 Dec; 42(6):590-605. PubMed ID: 17433436
[TBL] [Abstract][Full Text] [Related]
4. Selective upregulation of the expression of plasma membrane calcium ATPase isoforms upon differentiation and 1,25(OH)2D3-vitamin treatment of colon cancer cells.
Ribiczey P; Papp B; Homolya L; Enyedi Á; Kovács T
Biochem Biophys Res Commun; 2015 Aug; 464(1):189-94. PubMed ID: 26116539
[TBL] [Abstract][Full Text] [Related]
5. Calcium efflux activity of plasma membrane Ca2+ ATPase-4 (PMCA4) mediates cell cycle progression in vascular smooth muscle cells.
Afroze T; Yang G; Khoshbin A; Tanwir M; Tabish T; Momen A; Husain M
J Biol Chem; 2014 Mar; 289(10):7221-7231. PubMed ID: 24448801
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane Ca2+-ATPase regulates Ca2+ signaling and the proliferation of airway smooth muscle cells.
Chen YF; Cao J; Zhong JN; Chen X; Cheng M; Yang J; Gao YD
Eur J Pharmacol; 2014 Oct; 740():733-41. PubMed ID: 24912144
[TBL] [Abstract][Full Text] [Related]
7. A C-terminal di-leucine motif controls plasma membrane expression of PMCA4b.
Antalffy G; Pászty K; Varga K; Hegedűs L; Enyedi Á; Padányi R
Biochim Biophys Acta; 2013 Dec; 1833(12):2561-2572. PubMed ID: 23830917
[TBL] [Abstract][Full Text] [Related]
8. Plasma membrane calcium ATPase 4b inhibits nitric oxide generation through calcium-induced dynamic interaction with neuronal nitric oxide synthase.
Duan W; Zhou J; Li W; Zhou T; Chen Q; Yang F; Wei T
Protein Cell; 2013 Apr; 4(4):286-98. PubMed ID: 23549614
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase Inhibitor Treatment Increases the Expression of the Plasma Membrane Ca
Hegedüs L; Padányi R; Molnár J; Pászty K; Varga K; Kenessey I; Sárközy E; Wolf M; Grusch M; Hegyi Z; Homolya L; Aigner C; Garay T; Hegedüs B; Tímár J; Kállay E; Enyedi Á
Front Oncol; 2017; 7():95. PubMed ID: 28596940
[TBL] [Abstract][Full Text] [Related]
10. Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.
Bredoux R; Corvazier E; Dally S; Chaabane C; Bobe R; Raies A; Moreau A; Enouf J
Platelets; 2006 Sep; 17(6):421-33. PubMed ID: 16973504
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling.
Yi X; Wei W; Wang SY; Du ZY; Xu YJ; Yu XD
Biochem Pharmacol; 2008 May; 75(9):1697-705. PubMed ID: 18342836
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells.
Aung CS; Ye W; Plowman G; Peters AA; Monteith GR; Roberts-Thomson SJ
Carcinogenesis; 2009 Nov; 30(11):1962-9. PubMed ID: 19755660
[TBL] [Abstract][Full Text] [Related]
13. P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b.
Naffa R; Vogel L; Hegedűs L; Pászty K; Tóth S; Kelemen K; Singh N; Reményi A; Kállay E; Cserepes M; Tóvári J; Grusch M; Enyedi Á
Cells; 2020 May; 9(5):. PubMed ID: 32414111
[TBL] [Abstract][Full Text] [Related]
14. The plasma membrane Ca2+ pump isoform 4a differs from isoform 4b in the mechanism of calmodulin binding and activation kinetics: implications for Ca2+ signaling.
Caride AJ; Filoteo AG; Penniston JT; Strehler EE
J Biol Chem; 2007 Aug; 282(35):25640-8. PubMed ID: 17595168
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.
Munster PN; Troso-Sandoval T; Rosen N; Rifkind R; Marks PA; Richon VM
Cancer Res; 2001 Dec; 61(23):8492-7. PubMed ID: 11731433
[TBL] [Abstract][Full Text] [Related]
16. PSD-95 mediates membrane clustering of the human plasma membrane Ca2+ pump isoform 4b.
Padányi R; Pászty K; Strehler EE; Enyedi A
Biochim Biophys Acta; 2009 Jun; 1793(6):1023-32. PubMed ID: 19073225
[TBL] [Abstract][Full Text] [Related]
17. Platelet PMCA- and SERCA-type Ca2+ -ATPase expression in diabetes: a novel signature of abnormal megakaryocytopoiesis.
Chaabane C; Dally S; Corvazier E; Bredoux R; Bobe R; Ftouhi B; Raies A; Enouf J
J Thromb Haemost; 2007 Oct; 5(10):2127-35. PubMed ID: 17883705
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells.
Cheng HT; Hung WC
Oncol Rep; 2013 Mar; 29(3):1238-44. PubMed ID: 23242251
[TBL] [Abstract][Full Text] [Related]
19. Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines.
Lee WJ; Roberts-Thomson SJ; Holman NA; May FJ; Lehrbach GM; Monteith GR
Cell Signal; 2002 Dec; 14(12):1015-22. PubMed ID: 12359307
[TBL] [Abstract][Full Text] [Related]
20. Characterization of PMCA isoforms and their contribution to transcellular Ca2+ flux in MDCK cells.
Kip SN; Strehler EE
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F122-32. PubMed ID: 12388403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
